Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer()

Accumulating evidence demonstrates important roles for histone deacetylase in tumorigenesis (HDACs), highlighting them as attractive targets for antitumor drug development. Histone deactylase inhibitors (HDACIs), which have shown favorable anti-tumor activity with low toxicity in clinical investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tao, Chen, Yihua, Li, Jingjie, Yang, Feifei, Wu, Haigang, Dai, Fujun, Hu, Meichun, Lu, Xiaoling, Peng, Yi, Liu, Mingyao, Zhao, Yongxiang, Yi, Zhengfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234873/
https://www.ncbi.nlm.nih.gov/pubmed/25220594
http://dx.doi.org/10.1016/j.neo.2014.07.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234873/
https://www.ncbi.nlm.nih.gov/pubmed/25220594
http://dx.doi.org/10.1016/j.neo.2014.07.009

Ejemplares similares